Dare To Change
HKSTPC Golden Technopreneur Award – Provectus Therapeutics
As the demand for personalized cancer therapies and drug development increase rapidly, there is a growing need for more efficient drug screening methods that can identify the most promising therapies for individual patients.
Provectus Therapeutics aims to accelerate novel drug development and personalized treatment for all individuals by implementing cutting-edge technologies. Our proprietary platform – Next Generation Drug Screening AI Platform, provide high resolution tumor analysis and high throughput drug screening experiments for:
- Full Understanding of Tumor Biology & Precision Oncology
- Fast Identification of Novel Druggable Target in tumor
- Accelerate drug development at preclinical stage (i.e., cell / gene therapy)
For more information, please contact dare.to.change@ydc.org.hk
Showcase
